What a Wegovy Compounding Pharmacy Actually Sells in 2026

Compounded semaglutide providers compared

Lowest start: Mochi Health, about $140 a month at the lowest dose. No membership: Curex, about $200 a month for the pill. One price at most doses: Willow. Real Wegovy without insurance: NovoCare, Novo Nordisk's own pharmacy. Insured, or on Medicare: real Wegovy usually costs you less. Each option is explained below.

Mochi Health: lowest starting price

Mochi bills in two parts. The compounded semaglutide is priced by dose, and a $79 monthly membership covers the care team. It says it has more than 400 board-certified providers, including obesity medicine doctors. All-in, that's about $140 a month at the lowest dose, rising to about $270 at the top dose. Mochi also sells a compounded semaglutide pill, from about $140 a month all-in. Its homepage shows the medicine price alone, so add the membership before you compare.

Curex: no membership fee

Curex sells compounded semaglutide with no membership fee. The visit, medicine and shipping are in one price. The catch is its "from $149" headline, which needs a year paid upfront at the lowest dose. Month to month, the pill costs about $200 and the shot about $250 at the starting dose. Both cost about $50 more at higher doses.

Fridays: coaching and a dietitian included

Fridays sells a program, with dietitian access and group coaching at either price. It costs about $150 a month with a full year paid upfront, or about $280 month to month. Fridays is rated F by the BBB, with many unanswered refund complaints. Try it month to month before you commit a full year.

Henry Meds: pill or shot, all-in

Henry Meds puts the medicine, visits, supplies and shipping into one monthly price, with no membership. The pill starts at about $250 a month and the shot at about $300. Prepaying 6 or 12 months lowers both. Henry says the price varies with your dose. It doesn't publish its higher-dose prices. Lab tests aren't included. See our Henry Meds review.

Willow: one price up to 3.5 mg

Willow charges about $300 a month at every dose up to 3.5 mg, as a shot or a tablet that dissolves under the tongue. Only its 7 mg shot costs more, about $400. There is no membership fee. Willow is LegitScript certified, an independent check that an online pharmacy or clinic follows the law. It names its partner pharmacies. It serves 36 states and has no live video visits.

Real Wegovy: self-pay, insurance and Medicare

NovoCare, Novo Nordisk's own pharmacy program, sells real Wegovy without insurance. The pill costs about $150 the first month, about $200 the second, then about $300. The pen costs about $350 a month, or about $400 at the 7.2 mg dose. New patients pay about $200 for their first two pen fills through December 31, 2026. You can pick it up at a local pharmacy or have it mailed home.

With private insurance that covers Wegovy, the savings card can bring a fill down to as little as $25. It takes off at most $100 per monthly fill. On Medicare, the GLP-1 Bridge charges $50 a month from July 2026 through December 2027, if you qualify. It covers the Wegovy pen and pill, Foundayo and the Zepbound KwikPen. It never covers compounded semaglutide. Wegovy cost has every route.

Ro once sold compounded semaglutide. It now sells only brand-name drugs, including the Wegovy pill and pen. If a site still lists Ro as a cheap compounded source, that listing is out of date. See our Ro review.

Is "compounded Wegovy" actually a real, legal thing?

No. Wegovy is Novo Nordisk's trademarked, FDA-approved semaglutide for weight management, with a higher top dose than Ozempic. Novo Nordisk owns the name, and the FDA approved its finished product. No pharmacy can copy that product and sell it under the Wegovy name.

What a licensed pharmacy can do is compound the medicine itself, semaglutide, under its generic name. Compounding means mixing a drug for one patient on a prescription. When an ad says "compounded Wegovy," it's either sloppy shorthand or a misleading label. For a purchase this size, that difference is worth a pause.

Novo Nordisk fights hard over that line. By April 2025 it had filed more than 100 lawsuits against sellers of compounded semaglutide. That month, a court permanently barred one compounding pharmacy from selling knockoff semaglutide. Other court orders made sellers post notices that their products were never reviewed by the FDA.

• Wegovy: Novo Nordisk's trademarked, FDA-approved semaglutide for weight management. No one else may compound it or sell it under that name.
• Compounded semaglutide: the same medicine, mixed by a licensed pharmacy for one patient. Legally a different, unbranded product.
• A warning sign: a seller that names its product "compounded Wegovy" is misusing a trademark, and that says something about how it operates.

Is compounded semaglutide, the Wegovy alternative, still legal in 2026?

Yes, through a narrower door than during the shortage years. From 2022 to early 2025, semaglutide was on the FDA's drug shortage list, which let pharmacies make it broadly. The FDA declared the shortage over on February 21, 2025. Its grace period ended April 22, 2025 for 503A pharmacies, which mix drugs for individual patients. It ended May 22, 2025 for 503B outsourcing facilities, which make larger batches.

What remains is the individual-patient route. A state-licensed pharmacy can still make semaglutide for a named patient when a prescriber documents a medical reason. An allergy to an ingredient in the brand-name drug is one example. The FDA puts it plainly: compounded drugs should only be used when an FDA-approved drug can't meet a patient's medical needs.

On April 30, 2026, the FDA also proposed not adding semaglutide, tirzepatide and liraglutide to its list of bulk drugs that 503B facilities may use. The comment period closed July 30, 2026, and no final decision has been issued. That proposal covers 503B facilities only, not 503A pharmacies. Some telehealth brands, Henry Meds among them, say they may use either kind. Ask which one fills yours.

How much less does compounded semaglutide cost than brand-name Wegovy?

Less than the list price suggests. Wegovy's list price, before any discount, is about $1,350 a month, and Novo Nordisk says it will drop to $675 on January 1, 2027. Almost no one pays it. The fair comparison is NovoCare's self-pay price. Here's what a first year costs on each route.

• NovoCare pen, up to 2.4 mg: about $4,250 in the first year if you start by December 31, 2026. That is two intro fills at about $200, then 11 fills at about $350, since each box lasts 28 days.
• NovoCare pill, following the label's dose steps: about $3,350 in the first year.
• Mochi Health, year paid upfront: about $1,310 if you stay at the lowest dose all year. Higher doses cost more.
• Curex, year paid upfront: about $1,790 at the lowest dose.
• Fridays, year paid upfront: about $1,800.
• Willow: about $3,600 a year at doses up to 3.5 mg.
• Insured, savings card: as little as $25 a fill. On Medicare, the Bridge: $50 a month. No compounded price beats either.

Is compounded semaglutide the same quality and safety as Wegovy?

Same medicine, different oversight. The FDA reviews Wegovy's strength, sterility and batch-to-batch consistency. It does not review compounded drugs for safety, effectiveness or quality before they are sold. So no FDA check confirms that your vial matches the last one. Some compounded versions also add vitamin B12 or other ingredients, and the FDA hasn't reviewed those mixes either. The pharmacy behind your prescription matters more than the brand on the website.

Red flags: how to spot a legit vs. sketchy compounding pharmacy

• Misused brand name: it sells "compounded Wegovy" instead of compounded semaglutide.
• No pharmacy answer: it won't say whether a state-licensed US pharmacy fills your prescription, even when you ask.
• Salt forms: the label says semaglutide sodium or semaglutide acetate. The FDA says these are different ingredients, with no lawful basis for compounding.
• No medical review: there's no online visit or clinician check, just a checkout page.
• Hidden total: it won't show the full monthly price, membership included, before you pay.
• Too cheap to explain: the price sits far below every provider on this page, with no reason given.

Who compounded semaglutide is and isn't a good fit for

• Good fit: women without coverage for weight-loss drugs who want supervised semaglutide at the lowest cash price, with a medical reason their provider documents.
• Not ideal: women whose private plan covers Wegovy, or who qualify for the Medicare Bridge. Real Wegovy will almost always cost less.
• Always ask: which pharmacy makes your medicine, and how it tests each batch.

If weight change in your 40s or 50s brought you here, the hormonal side matters too. See GLP-1 medications and menopause weight gain for that fuller picture.